Title: Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Journal: Current opinion in ophthalmology 20120901
Title: Ingenol mebutate gel for actinic keratosis.
Journal: The New England journal of medicine 20120315
Title: Ivacaftor, vismodegib, and ingenol mebutate.
Journal: Journal of the American Pharmacists Association : JAPhA 20120101
Title: What's new in the treatment of actinic keratoses?
Journal: Cutis 20110201
Title: Topical antineoplastic agents in the treatment of mucocutaneous diseases.
Journal: Current problems in dermatology 20110101
Title: Novel antileukemic compound ingenol 3-angelate inhibits T cell apoptosis by activating protein kinase Ctheta.
Journal: The Journal of biological chemistry 20100730
Title: The skin cancer chemotherapeutic agent ingenol-3-angelate (PEP005) is a substrate for the epidermal multidrug transporter (ABCB1) and targets tumor vasculature.
Journal: Cancer research 20100601
Title: Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.
Journal: European journal of haematology 20100301
Title: Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.
Journal: Cancer research 20090515
Title: PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
Journal: The Australasian journal of dermatology 20090201
Title: Antiproliferative activity of PEP005, a novel ingenol angelate that modulates PKC functions, alone and in combination with cytotoxic agents in human colon cancer cells.
Journal: British journal of cancer 20081202
Title: Neutrophils are a key component of the antitumor efficacy of topical chemotherapy with ingenol-3-angelate.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20061201
Title: Induction of senescence in diterpene ester-treated melanoma cells via protein kinase C-dependent hyperactivation of the mitogen-activated protein kinase pathway.
Journal: Cancer research 20061015
Title: HIV type 1 inhibition by protein kinase C modulatory compounds.
Journal: AIDS research and human retroviruses 20060901
Title: PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC.
Journal: Blood 20050815
Title: Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells.
Journal: Molecular cancer therapeutics 20041201
Title: Characterization of the interaction of ingenol 3-angelate with protein kinase C.
Journal: Cancer research 20040501
Title: Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death.
Journal: Cancer research 20040415
Title: Kedei N, et al. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res. 2004 May 1;64(9):3243-55.
Title: Hampson P, et al. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood. 2005 Aug 15;106(4):1362-8.
Title: Ghoul A, et al. Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells. Cancer Res. 2009 May 15;69(10):4260-9.
